Monday, June 15, 2026

North Korea Issues New Commemorative Stamps for 9th Workers’ Party Congress

North Korea has issued new commemorative stamps for the 9th Congress of the Workers' Party, reflecting its ideological principles and goals.

Trump’s Bold Claim: Why Greenland’s Ownership is Crucial for U.S. National Security

Trump emphasizes Greenland's ownership for security, critiques NATO, and touts U.S. economic successes during WEF speech in Davos.

From Deadpool to K-Pop: Ryan Reynolds’ Thrilling Appearance in Stray Kids’ Music Video

To celebrate the release of its new mini album, ATE, K-pop boy band Stray Kids held a press conference at 11 a.m. today.

Tag: Zymfentra

Celltrion’s Zymfentra Just Hit a New U.S. Prescription Record and the Growth Looks Serious

Celltrion's Zymfentra treatment saw a 185% surge in U.S. prescriptions, driven by effective marketing and reimbursement strategies.

How Celltrion’s Local Production Strategy Eliminates U.S. Drug Tariffs Influence

Celltrion resolves tariff impacts on U.S. sales, boosting local production and growth opportunities for its biosimilars, including Zymfentra.

How Zymfentra’s Prescription Rates Tripled in January: A Game-Changer for Celltrion

Celltrion's Zymfentra sees a 213% rise in U.S. prescriptions, marking significant growth since its launch, driven by market demand.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

K-Bio Targets the U.S. Market: Celltrion and Samsung Bioepis Close in on Originator Drugs

Celltrion and Samsung Bioepis are expanding in the U.S. market, showing strong growth in biosimilars like Zymfentra and Hadlima.

Top News

- Our Sponsors Ad -

Follow us